Related Experiment Videos
Diminished erythroid ferrochelatase activity in protoporphyria.
The Journal of Laboratory and Clinical Medicine
|July 1, 1975
Summary
Patients with protoporphyria show normal synthesis of key heme precursors but significantly reduced ferrochelatase activity in bone marrow and reticulocytes. This explains elevated blood protoporphyrin levels and mild anemia in these cases.
Area of Science:
- Biochemistry
- Hematology
- Metabolic Disorders
Background:
- Protoporphyria is characterized by increased protoporphyrin levels.
- The precise biochemical defect in erythroid cells requires further elucidation.
Purpose of the Study:
- To investigate the enzymatic activity related to heme synthesis in patients with protoporphyria.
- To determine the ferrochelatase activity in erythroid tissues of affected individuals.
Main Methods:
- Assessed enzymatic synthesis of aminolevulinic acid and prophobilinogen in erythroid tissue.
- Measured ferrochelatase activity in bone marrow and peripheral blood reticulocytes.
- Compared enzyme activities to normal control subjects.
Main Results:
- Normal enzymatic synthesis of aminolevulinic acid and prophobilinogen was observed.
- Bone marrow ferrochelatase activity was less than 25% of normal controls.
- Peripheral blood reticulocyte ferrochelatase activity was less than 10% of controls.
Conclusions:
- Reduced ferrochelatase activity is a key metabolic abnormality in protoporphyria.
- This deficiency biochemically explains elevated blood protoporphyrin concentrations.
- The findings clarify the cause of minimally impaired hemoglobin synthesis in protoporphyria.